Keywords: NovAliX, Graffinity, Drug discovery services, M&A

France’s NovAliX acquires majority interest in Germany’s Graffinity

Article | 16 November 2010

Print This

Strasbourg, France-based NovAliX said this morning that it has entered into a definitive agreement to acquire a majority interest in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in